CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 949 enrolled
Drug / intervention
pain therapy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00003162
NCT00003162Phase 3Completed
CompareCT.gov

Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life

Radiation Therapy Oncology Group·interventional·Posted Apr 18, 2003·Updated Nov 17, 2015

In Brief

A Phase 3 clinical trial evaluating pain therapy and radiation therapy for Breast Cancer and 3 related conditions. Completed, enrolled 949 participants across 253 sites in 2 countries.

Detailed Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective for bone metastases. PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have bone metastases from breast or prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer, Metastatic Cancer, Pain, Prostate Cancer
CountriesCanada, United States
CollaboratorsNational Cancer Institute (NCI), North Central Cancer Treatment Group

Timeline

Phase 3CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 18, 2003
Enrollment StartFeb 1, 1998
Primary CompletionJul 1, 2003
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 23.2 years ago

Interventions

pain therapyprocedure

radiation therapyradiation